If you have been reading about reversed-phase HPLC and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-12-17. Numbers and descriptions here follow the published literature rather than marketing material.
Independent verification is central to quality control because the compound is not produced under pharmaceutical manufacturing standards. Third-party laboratories can measure purity, identity, residual solvents, and microbial contamination, though the scope of testing varies between services. Reported analyses of vendor samples have shown batch-to-batch variation in peptide content and the presence of truncated or oxidized species. How much of this variation reflects synthesis conditions versus storage and shipping is not well characterized. No harmonized reference standard exists for the material as sold.
Handling guidance for melanotan II follows general practice for small synthetic peptides rather than a product-specific monograph. Lyophilized powder is typically kept at minus twenty degrees Celsius or colder, protected from light and moisture, because warmth and humidity accelerate degradation. Once reconstituted, solutions are usually refrigerated and used within a short window, as hydrolysis and microbial growth both become concerns. Repeated freeze-thaw cycles are generally avoided. These conventions come from laboratory peptide chemistry and not from formal stability studies on this specific compound.
Analytical confirmation of identity relies on mass spectrometry, most often coupled to liquid chromatography. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and provides a purity estimate based on peak area. Electrospray ionization mass spectrometry then confirms the expected molecular mass, while tandem mass spectrometry can map the fragment sequence. For research-grade material, these two techniques together form the standard minimum. Purity figures reported by vendors are frequently not traceable to an independent laboratory.
Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Freely soluble in water | Dissolves readily in aqueous buffer |
| Typical storage temperature | -20 °C or below | Protect from light and moisture |
| Typical analytical method | Reversed-phase HPLC and LC-MS | Purity estimate plus mass confirmation |
| Unit of measure | Milligram per vial | Content varies by vendor |
Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.
Lyophilized peptide powder is generally stored frozen, protected from light and moisture. Tryptophan residues are susceptible to oxidation, and the lactam bridge can hydrolyze under strongly acidic or basic conditions. Solutions prepared for laboratory work degrade faster than dry powder, and repeated freeze-thaw cycles accelerate loss. Common practice is to aliquot solutions before freezing and to avoid alkaline buffers. Reported stability windows vary with concentration, buffer, and temperature, so exact shelf lives are method-specific rather than universal.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
Pushpa Bhargava, founding director of the CSIR's Centre for Cellular and Molecular Biology in Hyderabad, endorsed the letter, calling Ayyadurai's sacking the worst of many cases he had seen of "vindictiveness in the CSIR" and accused CSIR administration of being "impervious to healthy and fair criticism". The incident was seen as an example of the difficulty some Indian expatriate professionals may encounter returning home after growing accustomed to the more direct management style of the U.S.
Normally, joint cartilages have proteoglycan complexes, which are proteins with side chains made of glycosaminoglycans such as keratan sulfate and chondroitin sulfate attached to strands of hyaluronic acid. The glycosaminoglycan side chains are polyanionic, which causes adjacent side chains to push each other away and create a "bottle brush", where hyaluronic acid is the stem and the side chains are the bristles. When pressure is exerted on the joint, fluids move between the chondrocytes and synovial fluid, exchanging nutrients. In degenerative joint disease, the proteoglycan complexes start disappearing, and the hyaluronate becomes poorer in quality and scarcer. This lowers the viscosity of the synovial fluid (which increases friction) and causes white blood cells and enzymes to enter and effect cartilage degradation and inflammation. Steroids that are released as a result kill the chondrocytes. The remaining chondrocytes have trouble exchanging nutrients with the synovial fluid, which would allow them to repair some damages. The mechanism of PSGAG in vivo is based on observations and studies in vitro. PSGAG inhibits many of the catabolic enzymes that degrade cartilage, proteoglycans, and hyaluronic acid. The enzymes that are inhibited include serine proteases, which play a role in the IL-1 degradation of proteoglycans and collagen; lysosomal enzymes that cause proteoglycans to dissociate from hyaluronic acid; elastase; metalloproteinases such as stromelysin, which degrade cartilage matrix proteins; collagenases such as cathepsin B1; and hyaluronidase.
The IDF also said that it killed two Lebanese militants attempting to infiltrate the border and plant an explosive at an IDF post. Two Israeli soldiers were killed and nine others were injured in Hezbollah attacks in the vicinity of the Lebanese border. Three rockets launched by Hezbollah to Metula caused fires and damaged electric infrastructure. The IDF said that its jets struck more than a hundred Hezbollah rocket launchers and other Hezbollah sites in its heaviest air strikes since the Israel–Hezbollah conflict started in October 2023. An Israeli strike in al-Haniyeh wounded four people. The Lebanese National News Agency reported that Israeli airstrikes targeted Mahmoudieh, Ksar al-Aroush, and Birket Jabbour. On 20 September, an Israeli strike in the Dahieh suburb of Beirut killed Ibrahim Aqil, the acting commander of the elite Redwan Force and other personnel including Ahmad Mahmoud Wahabi, a senior commander of Hezbollah while they were in a meeting. At least 45 people were killed including Aqil, Wahabi, another 14 high-ranking Hezbollah militants, three children, and seven women, while 68 people were injured. Heavy rocket fire was reported afterward in northern Israel. Hezbollah claimed that its Katyusha rockets struck the IDF base in Meron. Hezbollah also said that it targeted Israeli airbases, intelligence bases, and a tank. On 21 September, the IDF claimed to have "almost completely dismantled" Hezbollah's military chain of command. The IDF claimed that it destroyed thousands of rocket launchers. Four people were wounded in Israeli strikes.
Uranium tailings are waste by-product materials left over from the rough processing of uranium-bearing ore. They are not significantly radioactive. Mill tailings are sometimes referred to as 11(e)2 wastes, from the section of the US Atomic Energy Act of 1946 that defines them. Uranium mill tailings typically also contain chemically hazardous heavy metal such as lead and arsenic. Vast mounds of uranium mill tailings are left at many old mining sites, especially in Colorado, New Mexico, and Utah. Although mill tailings are not very radioactive, they have long half-lives. Mill tailings often contain radium, thorium and trace amounts of uranium.
Sources: en.wikipedia.org
By 15 January 1919, Poles had taken control of most of the province, and they engaged in heavy fighting with the regular German army and irregular units such as the Grenzschutz Ost. Fighting continued until the renewal of the truce between the Entente and Germany on 16 February. The truce also affected the front line in Greater Poland, but despite the ceasefire, skirmishes continued until the final signing of the Treaty of Versailles on 28 June 1919. The uprising is one of the two most successful Polish uprisings, the other being the Great Poland uprising of 1806, which ended with the entry of Napoleon's army on the side of the Poles fighting against Prussia. Many of the Greater Poland insurrectionists later took part in the Silesian Uprisings against German rule, which started in late 1919 and ended in 1921.
Causes: (a) Microvesicular: Aspirin (Reye's syndrome), ketoprofen, tetracycline (especially if expired) (b) Macrovesicular: Acetaminophen, methotrexate (c) Phospholipidosis: Amiodarone, total parenteral nutrition (d) Antiviral: nucleoside analogues (e) Corticosteroid (f) Hormonal: Tamoxifen
The draw took place on December 5, 2025, at the Kennedy Center in Washington, D.C. The draw ceremony began with FIFA presenting the first FIFA Peace Prize to Donald Trump, an award which fueled scrutiny and ridicule among human rights groups, analysts, and others. The 48 teams were divided into four pots of 12. Pot 1 consisted of the three hosts and the top nine teams from the November 2025 FIFA Men's World Ranking. Pots 2, 3, and 4 consisted of the remaining teams according to the ranking. The four winners of the UEFA playoffs and the two winners of the inter-confederation playoffs were not known at the time of the draw and thus were automatically allocated to Pot 4. The 12 groups were randomly formed by selecting one team from each of the four pots. With the exception of UEFA, no group could have more than one team from the same confederation drawn into it. The three host nations were pre-allocated to three groups for scheduling purposes. Mexico was placed in Group A, Canada in Group B, and the United States in Group D. The confederation restriction applied to all three potential winners of the inter-confederation playoffs. FIFA also announced that, "in the interest of ensuring competitive balance", the teams ranked first (Spain), second (Argentina), third (France), and fourth (England) would be drawn into opposite pathways. Therefore, should these teams win their groups, they would be unable to meet until the semifinals, and the first and second ranked teams would be unable to meet until the final.
Sources: en.wikipedia.org
== Mechanism of action == Copanlisib is an inhibitor of phosphatidylinositol-3-kinase (PI3K) with inhibitory activity predominantly against PI3K-α and PI3K-δ isoforms expressed in malignant B-cells. It has been shown to induce tumor cell death by apoptosis and inhibition of proliferation of primary malignant B cell lines.
Paul Hellquist, the game's lead designer, was often omitted from key design meetings, which he considered due to questioning Levine's choices; he redirected his frustration into improving the Medical Pavilion level that he was in charge of at that time. Near the anticipated completion date, 2K Games decided to give Irrational another three months to polish up the game, extending the crunch time the studio was already under. After early rounds of positive feedback from family and friends, 2K used a beta version to conduct wider focus tests of the first level. Initial feedback from players was negative; players were lost and confused by the level, did not know how to use newly-acquired powers, and missed key story information. Testers distrusted the Atlas character, who at the time was voiced in a southern accent one tester described as a "lecherous Colonel Sanders". Project lead Alyssa Finley called the feedback "brutal", but humbling: the team realized that they were making a complex game that was not accessible to a variety of players. The opening levels of the game were redesigned to be more deliberate experiences that taught players key mechanics. The lighting was adjusted, a quest marker added for player way finding, and Atlas was given an Irish accent to make him sound more trustworthy.
== Enrollment == From 2006 to 2019 the number of African-American students remained constant, but the numbers of other racial groups, including Hispanic/Latine and non-Hispanic white students increased. In 2006 the student count was 6,700, including 60 Hispanic/Latine students, in 2019 it was up to 7,700, including 260 Hispanic/Latine students, and in 2024 it was up to 9,808, including 476 Hispanic/Latine students. As of Fall of 2025, there were 11,559 students, being 9,554 undergraduates and 2,005 graduate students enrolled at Morgan, and 45% were non-Maryland residents. The largest sources of enrollment outside of Maryland were New York, New Jersey, and Pennsylvania. Almost 10% of the student population was international, including many from countries like Jamaica, Dominican Republic, Nigeria, and Saudi Arabia. As of Fall 2026, the new record number of enrollment is 12,477 students. The university’s enrollment growth is due not only to the growing interest in HBCUs in general, but also to the institution's dedicated recruiting efforts.
Sources: en.wikipedia.org
The lyophilized powder is generally held at minus twenty degrees Celsius or below, away from light and moisture. Reconstituted solutions are typically refrigerated and used quickly. These practices derive from general peptide handling rather than a formal stability study.
Reversed-phase liquid chromatography estimates purity, and mass spectrometry confirms molecular mass. Together they distinguish the intended peptide from truncated or modified forms. Sequence-level confirmation may use tandem mass spectrometry or amino acid analysis.
Because it is not made under pharmaceutical standards, purity and content can vary between vendors and batches. Independent testing has documented labeling discrepancies. A certificate of analysis from an accredited laboratory offers more assurance than a vendor's own claim.
No. It is a synthetic analogue carrying four amino acid changes, a lactam ring and an amidated C-terminus. The natural hormone is a linear thirteen-amino-acid peptide processed from proopiomelanocortin.